Luspatercept + Darbepoetin in MDS

NCT07096297 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

60

Enrollment

OTHER

Sponsor class

Conditions

MDS (Myelodysplastic Syndrome)

Interventions

DRUG: Luspatercept
DRUG: Darbeopoetin

Sponsor

Yale University

Collaborators

[object Object]